Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Lim

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|January 24, 2026
Adjuvant nivolumab for resected high-risk head and neck cancerAnnette M Lim, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Immunotherapy for Anaplastic Thyroid CarcinomaAnnette M Lim, Benjamin J Solomon
Current Oncology (Toronto, Ont.)|August 27, 2025
Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell CarcinomaAnnette M Lim, Sandro Porceddu, Danny Rischin
Immunotherapy|January 29, 2026
Cemiplimab in the treatment of cutaneous squamous cell carcinomaLuke S McLean, Annette M Lim, Danny Rischin
JAMA Oncology|December 30, 2020
Locoregional Radiotherapy in Metastatic Nasopharyngeal CancerAlesha A Thai, Lachlan J McDowell, Annette M Lim
Cancers|November 27, 2021
Biology and Treatment Advances in Cutaneous Squamous Cell CarcinomaAlesha A Thai, Annette M Lim, Benjamin J Solomon, et al.
Drugs & Aging|March 6, 2024
Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell CarcinomaLuke S McLean, Annette M Lim, Mathias Bressel, et al.
American Journal of Clinical Dermatology|December 13, 2022
The Current Treatment Landscape of Cutaneous Squamous Cell CarcinomaChia Yuen Chong, Michelle S Goh, Sandro V Porceddu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 19, 2024
Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapyKarda Cavanagh, Luke S McLean, Annette M Lim, et al.
Frontiers in Oncology|May 3, 2021
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell CarcinomaAnnette M Lim, Karda Cavanagh, Rodney J Hicks, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|January 24, 2026
Adjuvant nivolumab for resected high-risk head and neck cancerAnnette M Lim, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Immunotherapy for Anaplastic Thyroid CarcinomaAnnette M Lim, Benjamin J Solomon
Current Oncology (Toronto, Ont.)|August 27, 2025
Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell CarcinomaAnnette M Lim, Sandro Porceddu, Danny Rischin
Immunotherapy|January 29, 2026
Cemiplimab in the treatment of cutaneous squamous cell carcinomaLuke S McLean, Annette M Lim, Danny Rischin
JAMA Oncology|December 30, 2020
Locoregional Radiotherapy in Metastatic Nasopharyngeal CancerAlesha A Thai, Lachlan J McDowell, Annette M Lim
Cancers|November 27, 2021
Biology and Treatment Advances in Cutaneous Squamous Cell CarcinomaAlesha A Thai, Annette M Lim, Benjamin J Solomon, et al.
Drugs & Aging|March 6, 2024
Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell CarcinomaLuke S McLean, Annette M Lim, Mathias Bressel, et al.
American Journal of Clinical Dermatology|December 13, 2022
The Current Treatment Landscape of Cutaneous Squamous Cell CarcinomaChia Yuen Chong, Michelle S Goh, Sandro V Porceddu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 19, 2024
Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapyKarda Cavanagh, Luke S McLean, Annette M Lim, et al.
Frontiers in Oncology|May 3, 2021
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell CarcinomaAnnette M Lim, Karda Cavanagh, Rodney J Hicks, et al.
Pageof 5